Concerning genetic aspects related to neurodegeneration and dementia, post-mortem evaluation reported a strong correlation between Tau aggregates and Tau PET findings in MAPT mutation carriers ([18F]AV-1451 PET study) [70]. The gene discussed is MAPT; the disease is dementia.